Cadaverine Tartrate

Cadaverine Tartrate

SCHEMBL7202848

O=C([O-])C(O)C(O)C(=O)[O-].[Cu+].[Cu+]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3BCHECHRM1CHRM2CHRM3CHRM4CHRNA3CHRNA4CHRNB2CHRNB4ESR1ESR2GABRA1GABRB1GABRG2GBA1GHSRHRH1HTR1DHTR2AMAOBOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8UGCGrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.47
LMNA P02545 2/20 0.43
CA4 P22748 3/20 0.40
CYP3A4 P08684 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35
TP53 P04637 1/20 0.35
CA1 P00915 3/20 0.33
FAHD1 Q6P587 1/20 0.33
NFKB1 P19838 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SLC22A6 Q4U2R8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cadaverine Tartrate SCHEMBL27438908 1.00 TSHR (0.47) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL27670959 0.96 TSHR (0.44) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL28237556 0.96 TSHR (0.44) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL3160195 0.96 LMNA (0.48) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL28155424 0.93 TSHR (0.41) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL23855755 0.92 TSHR (0.47) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL223358 0.92 TSHR (0.47) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL5144678 0.92 TSHR (0.47) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL3591252 0.92 TSHR (0.47) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL5141545 0.92 TSHR (0.47) TSHRLMNACA4CYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6042848-A FOR CONTROLLING GROWTH OF UNDESIRABLE OR PATHOGENIC MICROORGANISMS IN VARIOUS LOCI OR MILIEU IN, ON, OR OUTSIDE THE BODY EMPLOYING ANTIMICROBIAL PEPTIDES AND METAL IONS THE BOARD OF TRUSTEES OF SOUTHERN ILLINOIS UNIVERSITY (US) 2000-03-28 US claimed
EP-0920327-A1 ENHANCEMENT OF ANTIMICROBIAL PEPTIDE ACTIVITY BY METAL IONS Southern Illinois University (US) 1999-06-09 EP claimed
WO-1998006419-A1 ENHANCEMENT OF ANTIMICROBIAL PEPTIDE ACTIVITY BY METAL IONS SOUTHERN ILLINOIS UNIVERSITY (US) 1998-02-19 WO claimed
EP-0004570-B1 THIOL ESTERS, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND A PROCESS FOR PREPARING CEPHALOSPORIN COMPOUNDS USING THE SAME Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1982-04-14 EP claimed
EP-0004570-A1 Thiol esters, process for their preparation, pharmaceutical compositions containing them and a process for preparing cephalosporin compounds using the same Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1979-10-17 EP claimed
EP-2709714-B1 APPARATUS FOR HEATING A TREATMENT REGION WITH AN ALTERNATING ELECTRIC FIELD INNOVOLINK LLC (US) 2019-01-16 EP disclosed
US-9956028-B2 Apparatus and method for heating biological targets INNOVOLINK, LLC (US) 2018-05-01 US disclosed
US-9901387-B2 Apparatus and method for heating adipose cells INNOVOLINK, LLC (US) 2018-02-27 US disclosed
US-9901742-B2 Apparatus and method for heating a treatment region with an alternating electric field INNOVOLINK, LLC (US) 2018-02-27 US disclosed
US-9675814-B2 Apparatus and method for obtaining a substantially constant current across a treatment region INNOVOLINK, LLC (US) 2017-06-13 US disclosed
EP-2709714-A1 APPARATUS AND METHOD FOR HEATING A TREATMENT REGION WITH AN ALTERNATING ELECTRIC FIELD Innovolink, LLC (US) 2014-03-26 EP disclosed
US-20120290050-A1 Apparatus and Method for Obtaining a Substantially Constant Current Across a Treatment Region INNOVOLINK, LLC 2012-11-15 US disclosed
WO-1998006419-A1 ENHANCEMENT OF ANTIMICROBIAL PEPTIDE ACTIVITY BY METAL IONS SOUTHERN ILLINOIS UNIVERSITY (US) 1998-02-19 WO disclosed
EP-0394822-B1 Oxygen absorbent MITSUBISHI GAS CHEMICAL CO (JP) 1994-07-13 EP disclosed
US-5180518-A Food preservatives MITSUBISHI GAS CHEMICAL CO., INC. (JP) 1993-01-19 US disclosed
EP-0394822-A1 Oxygen absorbent MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1990-10-31 EP disclosed
EP-0004570-B1 THIOL ESTERS, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND A PROCESS FOR PREPARING CEPHALOSPORIN COMPOUNDS USING THE SAME Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1982-04-14 EP disclosed
US-4314059-A Process for preparing cephalosporin compounds SHIBUYA CHISEI 1982-02-02 US disclosed
US-4258195-A Novel thiol esters and process for preparing cephalosporin compounds using same ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1981-03-24 US disclosed
EP-0004570-A1 Thiol esters, process for their preparation, pharmaceutical compositions containing them and a process for preparing cephalosporin compounds using the same Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1979-10-17 EP disclosed